BrainCells (BCI)

Cyclerion Therapeutics

This biopharmaceutical company develops neuropsychiatric therapies for patients with treatment-resistant depression and other neurodegenerative diseases.

CeNeRx

This biopharmaceutical company develops clinical-stage therapeutics for central nervous system disorders, such as depression and pain, for patients and healthcare providers.

Delix

This company develops non-hallucinogenic neuroplasticity-promoting medicines to treat neuropsychiatric and neurodegenerative conditions for patients with brain disorders.

BrainZell

The company develops brain organoid models and computational tools for pharmaceutical firms to discover central nervous system drugs and test their efficacy.

Neumora Therapeutics

This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.

Neuro3D SA

This company develops pharmaceutical treatments for central nervous system disorders such as schizophrenia and depression for the healthcare and medical research sectors.

Brain-to-Computer Interface

This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.

Cerevel Therapeutics

This biopharmaceutical company develops neuroscience medicines for patients with mental and neurological conditions including schizophrenia, Parkinson's disease and epilepsy.